ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

Treatment Doesn’t Always Follow Recommendations

February 25, 2005

In Brief: Wilson Names Director, MCW cancer Center; UAB Cancer Center Makes Three Appointments

February 9, 1996

In Brief: NIH Reviewers, Advisors To Get Increase In Honoraria; Price Leaving NCI for Maryland

March 14, 1980

NCI to Advise Women in 40s o Ask Doctor About Mammography, End Routine Screening

September 24, 1993

NCI Cooperative Group Clinical Trials Approved

November 27, 2009

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

November 1, 2012